Walgreens cuts 2026 store closures to under 100

A sharply reduced closure count

Walgreens now expects to close fewer than 100 US locations in 2026, a company spokesperson confirmed. That figure sits well below the roughly 700 closures once planned for this year, part of a broader restructuring push that has already reshaped the chain's national footprint. Inc, which compiled the running list of shuttered locations, first reported the updated tally.^[5]

On 14 October 2024, Walgreens Boots Alliance's board approved a footprint optimisation programme targeting about 1,200 store closures over three years.^[3] The revised 2026 figure suggests the company is now operating at a materially different pace, with the aggressive wind-down giving way to a more selective approach.

Sycamore Partners and the private pivot

Sycamore Partners completed its acquisition of Walgreens Boots Alliance on 28 August 2025, paying $11.45 per share and transitioning the company into a private standalone entity.^[1] The deal removed Walgreens from public markets after more than two decades as a listed company, handing Sycamore, a private equity firm specialising in consumer and retail businesses, direct control over its restructuring trajectory.

Chief Executive Mike Motz framed the transition as a reset. "Today represents an exciting new chapter and a turning point for Walgreens," Motz said.^[1] Motz said the company was renewing its focus on core pharmacy and retail operations, its stores and customer experience, building on progress already made.^[1]

The buyout split Walgreens Boots Alliance into five standalone companies, with the US retail pharmacy operation, trading as Walgreen Co., separated from its international and healthcare assets. Operating privately removes the quarterly earnings pressure that had been a constant backdrop to the closures debate, giving Sycamore room to recalibrate without public market scrutiny.

Jobs lost, a distribution centre gone

Walgreens filed a WARN Act notice with the Texas Workforce Commission on 18 February 2026, disclosing the closure of its Houston distribution centre on Greens Road, with 159 employees affected from 1 June 2026.^[4] The WARN Act requires employers to give 60 days' advance notice of mass layoffs, making the filing a legally mandated disclosure rather than a voluntary announcement.

The Houston closure is part of a wider rationalisation of Walgreens' logistics network as the company reduces its store count and aligns distribution capacity to a smaller physical footprint. Separately, job cuts linked to the private equity buyout have affected workers in Illinois, where Walgreens maintains significant corporate operations.

Individual closures and community pharmacy concerns

A Walgreens at 8628 S Cottage Grove Avenue in Chicago's South Side closed on 4 June, with the company citing theft and violence as factors in the decision. The closure drew attention in part because Walgreens was founded in 1901 on Chicago's South Side, making each withdrawal from that part of the city a pointed story.^[2]

Confirmed closures span at least a dozen US states and Washington DC. Community health advocates have raised concerns about pharmacy deserts, particularly in lower-income urban and rural communities where Walgreens has historically served as the primary retail pharmacy option.

The US retail pharmacy sector has been contracting under compounding pressures: digital competitors and mail-order fulfilment eating into front-of-store sales, rising operating costs, and tightening margins on prescription reimbursements from pharmacy benefit managers. CVS and Rite Aid have both executed significant closure programmes in recent years, placing Walgreens' pullback in an industry-wide context rather than a company-specific one.

Four new stores approved

Against the closures, Walgreens confirmed that four new store locations were approved for 2026, a company spokesperson said.^[2] The number is small relative to the closure count but signals the company is not in pure contraction mode. New openings in this environment typically reflect targeted bets on underserved markets or locations where prescription volumes justify the capital outlay.

The gap between closures and openings, sub-100 shutdowns against four new sites, points to a company shrinking its physical network while preserving the ability to invest selectively. Whether that balance shifts over the remainder of Sycamore's ownership will depend on pharmacy margin conditions and how the separated business units perform independently.

What the revised plan means

Walgreens grew from a single corner drugstore to a chain serving nearly nine million customers daily, but the network that scale produced is now being treated as a liability as much as an asset. The move to fewer than 100 closures in 2026 suggests Sycamore has concluded that the most acute underperformers have already been removed and that further aggressive cuts carry diminishing returns.

The original 1,200-store closure plan was approved when Walgreens was still publicly listed and under pressure to demonstrate decisive action to shareholders.^[3] As a private company, Motz and Sycamore can now pursue a longer time horizon, concentrating capital on stores and services rather than managing a headline closure number, and the sub-100 figure for 2026 is the clearest evidence yet that the strategy has shifted.